1. Home
  2. TLS vs PRQR Comparison

TLS vs PRQR Comparison

Compare TLS & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Telos Corporation

TLS

Telos Corporation

HOLD

Current Price

$4.04

Market Cap

358.0M

Sector

Technology

ML Signal

HOLD

Logo ProQR Therapeutics N.V.

PRQR

ProQR Therapeutics N.V.

HOLD

Current Price

$1.65

Market Cap

262.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TLS
PRQR
Founded
1969
2012
Country
United States
Netherlands
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
358.0M
262.5M
IPO Year
2020
2014

Fundamental Metrics

Financial Performance
Metric
TLS
PRQR
Price
$4.04
$1.65
Analyst Decision
Buy
Strong Buy
Analyst Count
5
4
Target Price
★ $7.90
$7.25
AVG Volume (30 Days)
★ 688.5K
600.5K
Earning Date
05-11-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 31.51
N/A
EPS
★ 0.03
N/A
Revenue
★ $164,805,000.00
N/A
Revenue This Year
$18.72
N/A
Revenue Next Year
$14.62
$13.92
P/E Ratio
$135.67
★ N/A
Revenue Growth
★ 52.21
N/A
52 Week Low
$3.79
$1.33
52 Week High
$8.36
$3.10

Technical Indicators

Market Signals
Indicator
TLS
PRQR
Relative Strength Index (RSI) 40.63 32.10
Support Level $3.93 $1.64
Resistance Level $4.67 $1.76
Average True Range (ATR) 0.20 0.09
MACD -0.03 -0.04
Stochastic Oscillator 13.53 8.06

Price Performance

Historical Comparison
TLS
PRQR

About TLS Telos Corporation

Telos Corp offers technology solutions and services that empower and protect the world's security-conscious organizations. The company delivers efficient, adaptable, and secure solutions that protect people, organizations, and information across government and industry. The company conducts its business through two reportable and operating segments: Security Solutions and Secure Networks. The Security Solutions segment is focused on cybersecurity, cloud, and identity solutions, and secure messaging through Xacta, Telos AMHS, and Telos ID offerings. The Secure Networks segment provides secure networking architectures and solutions to customers through secure mobility solutions, network management, and defense services. The majority of revenue is from Secure Networks.

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.

Share on Social Networks: